LpCat1 Promotes Malignant Transformation of Hepatocellular Carcinoma Cells by Directly Suppressing STAT1

被引:16
|
作者
Ji, Weidan [1 ,2 ]
Peng, Zhangxiao [1 ,2 ]
Sun, Bin [1 ,2 ]
Chen, Lei [1 ,2 ]
Zhang, Qin [1 ,2 ]
Guo, Minggao [3 ]
Su, Changqing [1 ,2 ]
机构
[1] Navy Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Mol Oncol, Shanghai, Peoples R China
[2] Navy Mil Med Univ, Natl Ctr Liver Canc, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Gen Surg, Sch Med, Shanghai, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词
LpCat1; STAT1; cell cycle; proliferation; metastasis; hepatocellular carcinoma (HCC); LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE 1; UP-REGULATION; PROGRESSION; EXPRESSION; PROLIFERATION; OVEREXPRESSION; INDUCTION; ARREST; GROWTH; PHASE;
D O I
10.3389/fonc.2021.678714
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hepatocellular carcinoma (HCC) is a malignant cancer with rapid proliferation and high metastasis ability. To explore the crucial genes that maintain the aggressive behaviors of cancer cells is very important for clinical gene therapy of HCC. LpCat1 was reported to be highly expressed and exert pro-tumorigenic effect in a variety of cancers, including HCC. However, its detailed molecular mechanism remained unclear. In this study, we confirmed that LpCat1 was up-regulated in HCC tissues and cancer cell lines. The overexpressed LpCat1 promoted the proliferation, migration and invasion of HCC cells, and accelerated cell cycle progression, while knocking down LpCat1 significantly inhibited cell proliferation, migration and invasion in vitro and in vivo, and arrested HCC cells at G0/G1 phase. Moreover, we proved for the first time that LpCat1 directly interacted with STAT1 which was generally recognized as a tumor suppressor in HCC. High levels of LpCat1 in HCC could inhibit STAT1 expression, up-regulate CyclinD1, CyclinE, CDK4 and MMP-9, and decrease p27kip1 to promote cancer progression. Conversely, down-regulation of LpCat1 would cause the opposite changes to repress the viability and motility of HCC cells. Consequently, we concluded that LpCat1 was a contributor to progression and metastasis of HCC by interacting with STAT1.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] ncRNA-Mediated High Expression of LPCAT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Liver Hepatocellular Carcinoma
    Sun, Qiu
    Liu, Xudong
    Peng, Qunlong
    Hu, Lei
    Jiang, Xiaochun
    [J]. JOURNAL OF IMMUNOLOGY RESEARCH, 2022, 2022
  • [22] Up-regulation of LPCAT1 is correlated with poor prognosis and promotes tumor progression in glioblastoma
    Xu, Jin
    Zhang, Yuan
    Chen, Honglin
    Zhang, Jianyong
    Zhu, Jie
    He, Yuchao
    Cui, Gang
    [J]. CYTOTECHNOLOGY, 2024, 76 (06) : 735 - 748
  • [23] Association of Genetic Polymorphisms in STAT1 Gene with Increased Risk of Hepatocellular Carcinoma
    Zhu, Zhong-Zheng
    Di, Jian-Zhong
    Gu, Wen-Ye
    Cong, Wen-Ming
    Gawron, Andrew
    Wang, Yu
    Zheng, Qi
    Wang, Ai-Zhong
    Zhu, Guanshan
    Zhang, Pin
    Hou, Lifang
    [J]. ONCOLOGY, 2010, 78 (5-6) : 382 - 388
  • [24] Distinct functions of phosphorylated and un-phosphorylated STAT1 in hepatocellular carcinoma
    Ma, B.
    Cao, W.
    Li, M.
    Liu, J.
    Wang, W.
    Peppelenbosch, M.
    Pan, Q.
    [J]. JOURNAL OF HEPATOLOGY, 2018, 68 : S660 - S661
  • [25] HKDC1 promotes tumor immune evasion in hepatocellular carcinoma by coupling cytoskeleton to STAT1 activation and PD-L1 expression
    Zhang, Yi
    Wang, Mingjie
    Ye, Ling
    Shen, Shengqi
    Zhang, Yuxi
    Qian, Xiaoyu
    Zhang, Tong
    Yuan, Mengqiu
    Ye, Zijian
    Cai, Jin
    Meng, Xiang
    Qiu, Shiqiao
    Liu, Shengzhi
    Liu, Rui
    Jia, Weidong
    Yang, Xianzhu
    Zhang, Huafeng
    Zhong, Xiuying
    Gao, Ping
    [J]. NATURE COMMUNICATIONS, 2024, 15 (01)
  • [26] HKDC1 promotes tumor immune evasion in hepatocellular carcinoma by coupling cytoskeleton to STAT1 activation and PD-L1 expression
    Yi Zhang
    Mingjie Wang
    Ling Ye
    Shengqi Shen
    Yuxi Zhang
    Xiaoyu Qian
    Tong Zhang
    Mengqiu Yuan
    Zijian Ye
    Jin Cai
    Xiang Meng
    Shiqiao Qiu
    Shengzhi Liu
    Rui Liu
    Weidong Jia
    Xianzhu Yang
    Huafeng Zhang
    Xiuying Zhong
    Ping Gao
    [J]. Nature Communications, 15
  • [27] Malignant Transformation of an HNF1a-Inactivated Hepatocellular Adenoma to Hepatocellular Carcinoma
    Hepkema, Joris T.
    Poelmann, Floris B.
    Gouw, Annette S. H.
    deHaas, Robbert J.
    Duiker, EvelienW.
    Blokzijl, Hans
    Klaase, Joost M.
    [J]. CASE REPORTS IN GASTROENTEROLOGY, 2020, 14 (03) : 577 - 585
  • [28] Lysophosphatidylcholine acyltransferase 1 (LPCAT1) upregulation in breast carcinoma contributes to tumor progression and predicts early tumor recurrence
    Abdelzaher, Eman
    Mostafa, Mohamed Farouk
    [J]. TUMOR BIOLOGY, 2015, 36 (07) : 5473 - 5483
  • [29] hSulf-1 inhibits cell proliferation and migration and promotes apoptosis by suppressing stat3 signaling in hepatocellular carcinoma
    Liu, Ling
    Ding, Feng
    Chen, Jiwei
    Wang, Boyong
    Liu, Zhisu
    [J]. ONCOLOGY LETTERS, 2014, 7 (04) : 963 - 969
  • [30] STAT1 promotes megakaryopoiesis downstream of GATA-1 in mice
    Huang, Zan
    Richmond, Terri D.
    Muntean, Andrew G.
    Barber, Dwayne L.
    Weiss, Mitchell J.
    Crispino, John D.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (12): : 3890 - 3899